Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02372738 | APO-MYCOPHENOLIC ACID | APOTEX INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02372746 | APO-MYCOPHENOLIC ACID | APOTEX INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02518511 | JAMP MYCOPHENOLIC ACID | JAMP PHARMA CORPORATION | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02511681 | MAR-MYCOPHENOLIC ACID | MARCAN PHARMACEUTICALS INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02511673 | MAR-MYCOPHENOLIC ACID | MARCAN PHARMACEUTICALS INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02264560 | MYFORTIC | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Delayed-Release) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02264579 | MYFORTIC | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Delayed-Release) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02465817 | SANDOZ MYCOPHENOLIC ACID | SANDOZ CANADA INCORPORATED | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Cancelled Pre Market |
| 02465809 | SANDOZ MYCOPHENOLIC ACID | SANDOZ CANADA INCORPORATED | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Cancelled Pre Market |